Linagliptin CAS: 668270-12-0 Soo saaraha

Linagliptin (magacyada ganacsiga Tradjenta iyo Trajetna) waa horjooge dipeptidyl peptidase-4 (DPP-4) kaas oo ay ansixisay US FDA bishii Maajo 2011 daawaynta nooca 2 ee sonkorowga oo ay weheliso cunto iyo jimicsi.Linagliptin (BI-1356) ayaa lagu tilmaamay inuu yahay mid awood badan oo xulasho ah, heer gaabinaya iyo xannibaadaha dheereeya ee DPP-4.Linagliptin wuxuu ka dhashay dadaallada hagaajinta ee xanthine-based DPP-4 inhibitors oo leh rasaastii ugu horreysay ee laga aqoonsaday ololaha HTS.

Dalbo ama Codso Xigasho

Faahfaahinta Alaabta

Tags Product

Codsiga iyo Saamaynta

Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) waa afka, aadka u doorta xannibaadaha dipeptidyl peptidase-4 waana wakiilka ugu horreeya ee fasalkiisa ee lagu baabi'iyo inta badan iyada oo loo marayo waddo aan kalyaha ahayn.Linagliptin waxa lagu tilmaamaa hal mar in loo isticmaalo daawaynta dadka waaweyn ee qaba nooca 2-aad ee sonkorowga. -1] iyo peptide insulinotropic-ku-tiirsan) iyo hoos u dhigidda dalxiisyada gulukooska ka dib.